 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
D619165 |
 |
(2S,3S)-2,3-bis(4-methylbenzoyloxy)butanedioic acid; bis((3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine) |
97%
|
$225/5G, $375/10G |
 |
Y1412353 |
 |
(R)-4-Methyl-3-cyclohexenamine |
95%
|
$1815/1g |
 |
Y3157874 |
 |
[1-(fluoromethyl)cyclobutyl]methanaminehydrochloride |
95%
|
$420/50mg, $605/100mg, $860/250mg, $1355/500mg, $1730/1g |
 |
D771395 |
 |
1-BOC-4-(2-AMINO-4-PYRIDINYL)-PIPERAZINE |
95%
|
$85/100mg, $120/250mg, $230/1g, $530/5g, $845/10g |
 |
Y1014241 |
 |
2,2-Difluoro-1-(pyridin-2-yl)ethanone |
95%
|
$305/100mg, $355/250mg, $1025/1g |
 |
Y3246499 |
 |
2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetonitrile |
95%
|
$190/50mg, $260/100mg, $365/250mg, $665/500mg, $860/1g |
 |
Y3259260 |
 |
2-{6-bromo-8-methylimidazo[1,2-a]pyridin-2-yl}ethan-1-amine hydrochloride |
95%
|
$445/50mg, $645/100mg, $920/250mg, $1445/500mg, $1850/1g, $3620/2.5g, $5350/5g |
 |
Y3160634 |
 |
3-ethoxy-2-(prop-2-yn-1-yloxy)benzaldehyde |
95%
|
$180/50mg, $210/100mg, $275/250mg, $505/500mg, $675/1g, $1315/2.5g, $1940/5g |
 |
Y3145817 |
 |
4-[2-(methylamino)ethoxy]benzene-1-sulfonamide hydrochloride |
95%
|
$345/50mg, $500/100mg, $715/250mg, $1120/500mg, $1430/1g, $2805/2.5g, $4145/5g |
 |
Y3150492 |
 |
5,6,7,8-tetrahydrophthalazine-1,4-diamine |
95%
|
$380/50mg, $550/100mg, $780/250mg, $1230/500mg, $1575/1g |
 |
Y3144027 |
 |
5-(3-Bromo-5-fluorophenyl)-2H-tetrazole |
95%
|
$445/500mg, $575/1g |
 |
D746219 |
 |
Benzenesulfonyl chloride, 4-(acetylamino)-3-chloro- |
95%
|
$70/100mg, $80/250mg, $130/1g, $290/5g |
 |
Y3269161 |
 |
diethyl cyclohex-3-ene-1,1-dicarboxylate |
95%
|
$180/50mg, $210/100mg, $275/250mg, $505/500mg, $675/1g |
 |
Y3150756 |
 |
ethyl (3-amino-1H-pyrazol-1-yl)acetate hydrochloride |
95%
|
$200/50mg, $275/100mg, $385/250mg, $580/500mg, $745/1g |
 |
Y1251612 |
 |
N-(4-Iodophenyl)-2-oxo-2H-chromene-3-carboxamide |
99%
|
$415/100mg |
 |
D780926 |
 |
p-Bromophenetole |
98%
|
$40/10g, $40/25g, $50/50g, $65/100g, $110/250g, $110/500g |
 |
|
|
|
 |
 |
 |